What is the name of voclosporin and an introduction to the names and specifications of different brands of drugs on the market?
Voclosporin is a new type of immunosuppressant, mainly used to treat patients with systemic lupus erythematosus (SLE) and lupus nephritis. It is a cyclosporine derivative that reduces immune system damage to the kidneys by inhibiting TT cell activation and the release of inflammatory mediators. Compared with traditional cyclosporine, cyclosporine has certain advantages in pharmacokinetic properties and safety, so it has gradually attracted clinical attention.
On the market, cyclosporin is mainly sold as an original drug. The brand name of the original drug is Lupkynis, which is developed and produced by Aurinia Pharmaceuticals. Common specifications include 10mg, 20mg and 40mg capsules. Each specification is suitable for patients with different weights and conditions. The drug has been approved for marketing in the United States and some overseas countries and is used in the treatment of lupus nephritis patients with proteinuria.

In addition to the original drug, generic drugs of cyclosporine are currently available in some countries and regions, but they have not yet been widely launched in the domestic market. Overseas generic drugs generally use the international nonproprietary name of Voclosporin (INN: Voclosporin), have similar specifications to the original drug, and are mainly supplied in capsule form. The advantage of generic drugs is that they are relatively cheap and have basically the same ingredients as the original drugs, which can reduce the burden on patients while ensuring the therapeutic effect.
For clinical use, doctors will choose appropriate specifications and dosages based on the patient's weight, renal function and disease progression when prescribing cyclosporine. Different brands and specifications may have differences in taking methods, medication frequency, and combined use with other drugs. Therefore, patients must strictly follow medical instructions when using them and purchase drugs through formal channels to ensure drug quality and drug safety.
Keyword tags:
Vociclosporin, trade name, brand specifications,Lupkynis, original drug, generic drug, market information, medication selection
Reference materials:https://www.drugs.com/monograph/voclosporin.html
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)